PSS10 COST PER RESPONDER OF USTEKINUMAB VERSUS ETANERCEPT IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS- ANALYSIS FROM THE ACCEPT TRIAL
May 1, 2010, 00:00
10.1016/S1098-3015(10)72713-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)72713-3/fulltext
Title :
PSS10 COST PER RESPONDER OF USTEKINUMAB VERSUS ETANERCEPT IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS- ANALYSIS FROM THE ACCEPT TRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72713-3&doi=10.1016/S1098-3015(10)72713-3
First page :
Section Title :
Open access? :
No
Section Order :
267